Variations in surgeon treatment recommendations for lobectomy in early-stage non-small-cell lung cancer by patient age and comorbidity
- PMID: 20162461
- PMCID: PMC3334325
- DOI: 10.1245/s10434-010-0946-y
Variations in surgeon treatment recommendations for lobectomy in early-stage non-small-cell lung cancer by patient age and comorbidity
Abstract
Background: Prior research suggests that older patients are less likely to undergo resection of early-stage non-small-cell lung carcinomas (NSCLCs). We surveyed surgeons to understand how their recommendations for lobectomy were influenced by age, the presence and severity of smoking-related lung disease, or by characteristics of the surgeons and their practices.
Methods: We surveyed surgeons caring for NSCLC patients regarding whether they would recommend lobectomy for hypothetical patients with early-stage NSCLC who varied by age (55 vs. 80 years) and comorbid illness (none, moderate, severe chronic obstructive pulmonary disease [COPD]). Ordinal logistic regression was used to identify the importance of patient, surgeon, and practice characteristics on surgery recommendations.
Results: Surgeons recommended lobectomy for nearly all patients who were 55 years old with no comorbidity (adjusted proportion 98.6%), 55 years old with moderate COPD (adjusted proportion 97.8%), or 80 years old with no comorbidity (adjusted proportion 98.1%). Fewer recommended lobectomy for 80-year-old patients with moderate COPD (adjusted proportion 82.3%), and far fewer recommended lobectomy for severe COPD, irrespective of age (adjusted rate 18.7% for the 55-year-old patient and 6.1% for the 80-year-old patient) (P < 0.002). Surgeons who enroll patients onto clinical trials (P = 0.03) were more likely than others to recommend lobectomy, but no other surgeon characteristic predicted recommendations.
Conclusions: Lower rates of lobectomy among older patients do not seem to be explained by age-related biases among surgeons for otherwise healthy patients.
Figures
References
-
- American Cancer Society. Cancer facts and figures, 2008. Atlanta, GA: American Cancer Society; 2008.
-
- Reis L, Eisner M, Kosary C. SEER cancer statistics review, 1973–1998. Bethesda, MD: National Cancer Institute; 2001.
-
- Scott WJ, Howington J, Feigenberg S, Movsas B, Pisters K American College of Chest Physicians. Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines. Chest. (2) 2007;132(3 Suppl):234S–42S. - PubMed
-
- [Accessed 7 Apr 2009.];NCCN Practice Guidelines in Oncology, Non-Small Cell Lung Cancer, version 2. 2009 Available at: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp.
-
- Boffa DJ, Allen MS, Grab JD, et al. Data from the society of thoracic surgeons general thoracic surgery database: the surgical management of primary lung tumors. J Thorac Cardiovasc Surg. 2008;135:247–54. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources